Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.

Kim M, Kim HI, Jeon MJ, Kim HK, Kim EH, Yi HS, Kim ES, Kim H, Kim BH, Kim TY, Kim SW, Kang HC, Kim WB, Chung JH, Shong YK, Kim TH, Kim WG.

Oral Oncol. 2018 Dec;87:97-103. doi: 10.1016/j.oraloncology.2018.10.029. Epub 2018 Oct 26.

PMID:
30527251
2.

Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.

van Velsen EFS, Stegenga MT, van Kemenade FJ, Kam BLR, van Ginhoven TM, Visser WE, Peeters RP.

Thyroid. 2018 Aug;28(8):976-981. doi: 10.1089/thy.2018.0066. Epub 2018 Jul 30.

PMID:
29848239
3.

Comparison of the Seventh and Eighth Editions of the American Joint Committee on Cancer/Union for International Cancer Control Tumor-Node-Metastasis Staging System for Differentiated Thyroid Cancer.

Kim M, Kim WG, Oh HS, Park S, Kwon H, Song DE, Kim TY, Shong YK, Kim WB, Sung TY, Jeon MJ.

Thyroid. 2017 Sep;27(9):1149-1155. doi: 10.1089/thy.2017.0050. Epub 2017 Jul 24.

PMID:
28635571
4.

Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.

Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME.

Thyroid. 2018 Oct;28(10):1301-1310. doi: 10.1089/thy.2017.0572.

PMID:
30141373
5.

Modification of the eight-edition tumor-node-metastasis staging system with N1b for papillary thyroid carcinoma: A multi-institutional cohort study.

Kim M, Kim HK, Kim HI, Kim EH, Jeon MJ, Yi HS, Kim ES, Kim H, Kim TH, Kim BH, Kim TY, Kang HC, Kim WB, Chung JH, Shong YK, Kim SW, Kim WG.

Oral Oncol. 2018 Nov;86:48-52. doi: 10.1016/j.oraloncology.2018.09.008. Epub 2018 Sep 13.

PMID:
30409319
6.

A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.

Nam SH, Bae MR, Roh JL, Gong G, Cho KJ, Choi SH, Nam SY, Kim SY.

Oral Oncol. 2018 Dec;87:158-164. doi: 10.1016/j.oraloncology.2018.11.003. Epub 2018 Nov 9.

PMID:
30527232
7.

[Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].

Stratmann M, Sekulla C, Dralle H, Brauckhoff M.

Chirurg. 2012 Jul;83(7):646-51. doi: 10.1007/s00104-011-2216-3. German.

PMID:
22273853
8.

Restaging of differentiated thyroid carcinoma by the sixth edition AJCC/UICC TNM staging system: stage migration and predictability.

Lang B, Lo CY, Chan WF, Lam KY, Wan KY.

Ann Surg Oncol. 2007 May;14(5):1551-9. Epub 2007 Feb 21.

PMID:
17318278
9.

Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.

Loh KC, Greenspan FS, Gee L, Miller TR, Yeo PP.

J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62.

PMID:
9360506
10.

Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma.

Kim TH, Kim YN, Kim HI, Park SY, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Kim K, Jeong JG, Kim SW, Chung JH.

Oral Oncol. 2017 Aug;71:81-86. doi: 10.1016/j.oraloncology.2017.06.004. Epub 2017 Jun 10.

PMID:
28688696
11.

Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).

Walczyk A, Kopczyński J, Gąsior-Perczak D, Pałyga I, Kowalik A, Chrapek M, Hejnold M, Góźdź S, Kowalska A.

Clin Endocrinol (Oxf). 2018 Dec 7. doi: 10.1111/cen.13910. [Epub ahead of print]

PMID:
30525210
12.

Prognostic value of the 8th edition of the tumor-node-metastasis classification for patients with papillary thyroid carcinoma: a single-institution study at a high-volume center in Japan.

Ito Y, Miyauchi A, Hirokawa M, Yamamoto M, Oda H, Masuoka H, Sasai H, Fukushima M, Higashiyama T, Kihara M, Miya A.

Endocr J. 2018 Jul 28;65(7):707-716. doi: 10.1507/endocrj.EJ18-0019. Epub 2018 Apr 20.

13.

Prognostic Implication of N1b Classification in the Eighth Edition of the Tumor-Node-Metastasis Staging System of Differentiated Thyroid Cancer.

Kim M, Jeon MJ, Oh HS, Park S, Song DE, Sung TY, Kim TY, Chung KW, Kim WB, Shong YK, Lee YM, Kim WG.

Thyroid. 2018 Apr;28(4):496-503. doi: 10.1089/thy.2017.0473. Epub 2018 Apr 5.

PMID:
29620964
14.

Reassessment of Differentiated Thyroid Cancer Patients Using the Eighth TNM/AJCC Classification System: A Comparative Study.

Shteinshnaider M, Muallem Kalmovich L, Koren S, Or K, Cantrell D, Benbassat C.

Thyroid. 2018 Feb;28(2):201-209. doi: 10.1089/thy.2017.0265. Epub 2018 Jan 22.

PMID:
29256827
15.

Prognostic value of the 8th tumor-node-metastasis classification for follicular carcinoma and poorly differentiated carcinoma of the thyroid in Japan.

Ito Y, Miyauchi A, Hirokawa M, Yamamoto M, Oda H, Masuoka H, Sasai H, Fukushima M, Higashiyama T, Kihara M, Miya A.

Endocr J. 2018 Jun 27;65(6):621-627. doi: 10.1507/endocrj.EJ17-0524. Epub 2018 Apr 4.

16.

Differentiated thyroid carcinoma. Follow-up of 264 patients from one institution for up to 25 years.

Gemsenjäger E, Heitz PU, Seifert B, Martina B, Schweizer I.

Swiss Med Wkly. 2001 Mar 24;131(11-12):157-63.

17.

Refining the eighth edition AJCC TNM classification and prognostic groups for papillary thyroid cancer with lateral nodal metastasis.

Kim HI, Kim K, Park SY, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Ahn HS, Kim SW, Kim TH, Chung JH.

Oral Oncol. 2018 Mar;78:80-86. doi: 10.1016/j.oraloncology.2018.01.021. Epub 2018 Feb 20.

PMID:
29496063
18.
19.

Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?

Kim M, Kim YN, Kim WG, Park S, Kwon H, Jeon MJ, Ahn HS, Jung SH, Kim SW, Kim WB, Chung JH, Shong YK, Kim TH, Kim TY.

Clin Endocrinol (Oxf). 2017 Mar;86(3):438-443. doi: 10.1111/cen.13254. Epub 2016 Nov 2.

PMID:
27731521
20.

Clinical Validation of the Prognostic Stage Groups of the Eighth-Edition TNM Staging for Medullary Thyroid Carcinoma.

Park SY, Cho YY, Kim HI, Choe JH, Kim JH, Kim JS, Oh YL, Hahn SY, Shin JH, Kim K, Kim SW, Chung JH, Kim TH.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4609-4616. doi: 10.1210/jc.2018-01386.

PMID:
30137493

Supplemental Content

Support Center